Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.20
Bid: 66.80
Ask: 68.80
Change: 0.40 (0.59%)
Spread: 2.00 (2.994%)
Open: 66.80
High: 68.20
Low: 66.80
Prev. Close: 67.80
CCEP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice: Coca-Cola European Partners

24 Mar 2020 09:11

RNS Number : 3509H
Mizuho International plc
24 March 2020
 

24th March 2020

 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

Coca-Cola European Partners plc

 

Pre-stabilisation Period Announcement

 

Mizuho International plc (contact: Syndicate Desk; telephone: 020 7090 6085) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/[1052]/2016 under the Market Abuse Regulation (EU/596/2014).

 

The securities:1

Issuer:

Coca-Cola European Partners plc

Aggregate nominal

amount:

EUR500mm expected

Description:

Senior Unsecured, RegS, Registered, Global Note due 2026

Offer price:

TBC

Other offer terms:

IPTs: m/s+240

Stabilisation:

Stabilisation

Manager(s):

Mizuho International plc (Stabilisation Coordinator)

HSBC Bank plc

Deutsche Bank AG, London Branch

Credit Suisse Securities (Europe) Limited

 

Stabilisation period

expected to start on:

24th March 2020

Stabilisation period

expected to end no

later than:

26th April 2020 (30 days after the proposed issue date of the

Securities)

Existence, maximum

size and conditions of

use of overallotment

facility:

The Stabilisation Manager(s) may overallot 5% of the aggregate nominal amount

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may overallot the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time9. Any stabilisation action or overallotment shall be conducted in accordance with all applicable laws and rules.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom10.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC, as amended (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State11.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAJIMLTMTMTMRM
Date   Source Headline
25th Jul 20234:00 pmRNSDirector/PDMR Shareholding
21st Jul 20232:30 pmRNSDirector/PDMR Shareholding
13th Jul 20233:30 pmRNSDirector/PDMR Shareholding
30th Jun 20234:30 pmRNSDirector/PDMR Shareholding
23rd Jun 20233:00 pmRNSDirector/PDMR Shareholding
8th Jun 202310:50 amRNSDirector/PDMR Shareholding
1st Jun 20232:15 pmRNSTotal Voting Rights
26th May 20234:30 pmRNSDirector/PDMR Shareholding
25th May 202311:30 amRNSResult of AGM
23rd May 20233:00 pmRNSDirector/PDMR Shareholding
18th May 202311:30 amRNSDirector/PDMR Shareholding
15th May 20233:30 pmRNSLetter to Shareholders
4th May 20234:00 pmRNSDirector/PDMR Shareholding
2nd May 20232:45 pmRNSTotal Voting Rights
25th Apr 20237:00 amRNSQ1 Trading Update & Interim Dividend Declaration
21st Apr 20234:58 pmRNSDirector/PDMR Shareholding
14th Apr 20231:30 pmRNSDirector/PDMR Shareholding
12th Apr 20239:00 amRNSNotice of AGM
3rd Apr 20232:45 pmRNSTotal Voting Rights
22nd Mar 202311:45 amRNSDirector/PDMR Shareholding
22nd Mar 202311:45 amRNSDirector/PDMR Shareholding
17th Mar 20233:30 pmRNSBlock listing Interim Review
17th Mar 202311:55 amRNSAnnual Financial Report
14th Mar 20239:45 amRNSDirector/PDMR Shareholding
13th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Mar 20233:50 pmRNSDirector/PDMR Shareholding
1st Mar 20233:20 pmRNSTotal Voting Rights
23rd Feb 202310:30 amRNSDirector/PDMR Shareholding
16th Feb 20237:00 amRNSPreliminary Unaudited Results Q4 & FY 2022
15th Feb 20234:35 pmRNSPrice Monitoring Extension
15th Feb 202310:00 amRNSDirectorate Change
1st Feb 20233:30 pmRNSTotal Voting Rights
23rd Jan 20234:30 pmRNSDirector/PDMR Shareholding
16th Jan 20232:30 pmRNSDirector/PDMR Shareholding
3rd Jan 20232:40 pmRNSTotal Voting Rights
21st Dec 20223:45 pmRNSDirector/PDMR Shareholding
1st Dec 20223:15 pmRNSTotal Voting Rights
23rd Nov 20228:00 amRNSDirector/PDMR Shareholding
15th Nov 20225:30 pmRNSDirector/PDMR Shareholding
4th Nov 20225:20 pmRNSDirector/PDMR Shareholding
2nd Nov 20227:00 amRNSQ3, Investor Event & Interim Dividend Declaration
1st Nov 20223:45 pmRNSTotal Voting Rights
21st Oct 20223:00 pmRNSDirector/PDMR Shareholding
14th Oct 20222:30 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:30 pmRNSTotal Voting Rights
22nd Sep 20223:00 pmRNSDirector/PDMR Shareholding
20th Sep 202210:00 amRNSBlock listing Interim Review
16th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20223:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.